Clinical Assistant Professor of Pharmacy Practice
Texas A&M University
Sara Rogers is a clinician-scientist with a significant impact in pharmacovigilance and pharmacogenomics. As a co-founder of the American Society of Pharmacovigilance, she has shaped crucial developments in drug safety and efficacy. Her leadership in forming the Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Collaborative Community has been pivotal in setting industry standards for pharmacogenetics testing. At Texas A&M University, where she holds joint appointments at the Institute of Biosciences and Technology, the School of Medicine, and the Irma Lerma Rangel School of Pharmacy, Rogers leads the precision medicine implementation at Texas A&M Health. This role underscores her expertise in bridging research with clinical applications, particularly in integrating pharmacogenetics into healthcare. Dr. Rogers is an organizational member of the NIH National Human Genomics Research Institute InterSociety Coordinating Committee where she develops educational resources that aid practitioners in navigating pharmacogenetics testing coverage. Her research, which focuses on patient access and reimbursement for pharmacogenetics testing, consistently informs policy and practice, demonstrating her comprehensive approach to advancing healthcare through precision medicine. Her commitment also extends to exploring ethical considerations in pharmacogenomics, further emphasizing her dedication to thoughtful and ethical scientific inquiry.
Pharmacogenomics Clinical Gems: Advancing the Pharmacist's Role in Personalized Medicine
Tuesday, December 10, 2024
2:00 PM – 3:30 PM